Kolon Life Science announced on June 26 that it will transfer comprehensive technology and rights related to 'mPPO' to Kolon Industries. The transferred technologies include all processes, analytical techniques, quality control, production technology, and patents related to mPPO. The contract amount is approximately 17 billion KRW. The contract period is from June 30, 2025, to July 31, 2025.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
